Search Results

Responsabilité sociale des entreprises Socialement responsable à chaque étape AcedrA Corporate Social Responsibility implique d'assumer la responsabilité de l'impact de nos actions sur l'environnement et les communautés au sein desquelles nous opérons. Cela inclut les impacts liés à la durabilité sociale, économique et environnementale. Une bonne gouvernance d'entreprise et agir conformément aux objectifs de développement durable sont des éléments essentiels de la responsabilité sociale des entreprises d'AcedrA. AcedrA depuis sa création s'est rendu compte que les efforts d'investissement dans ce domaine peuvent non seulement se traduire par un sentiment public positif, mais également par le succès à long terme de nos initiatives commerciales. AcedrA Corporate Social Responsibility (CSR) est une forme d'autorégulation par les entreprises, par laquelle elles surveillent et s'assurent que leur impact sur l'environnement et la société est positif. Pour ce faire, AcedrA a impliqué l'examen de tous les aspects des opérations d'une entreprise, y compris la conformité environnementale, sociale et de gouvernance avec les objectifs de développement durable. Les activités de RSE vont de l'approvisionnement en matériaux produits de manière éthique à l'investissement dans les économies locales ou à la défense des communautés marginalisées. En s'engageant dans des responsabilités significatives qui profitent aux parties prenantes, AcedrA a le potentiel de provoquer des changements positifs à l'échelle locale et régionale vers une durabilité à long terme. Les objectifs de développement durable Nous sommes heureux de faire partie du Pacte Mondial des Nations Unies En savoir plus sur le Pacte Mondial des Nations Unies Le Pacte mondial des Nations Unies est le plus grand au mondela durabilité d'entreprise initiative avec +13 000 entreprises participantes et autres parties prenantes dans plus de +170 pays avec deux objectifs : « Intégrer les dix principes dans les activités commerciales à travers le monde » et « Catalyser les actions à l'appui des objectifs plus larges de l'ONU, tels que comme le Objectifs de développement du millénaire (OMD) et Objectifs de développement durable (ODD) ". Pour aller de l'avant, le Pacte mondial des Nations Unies et ses signataires sont profondément investis et enthousiastes à l'idée de soutenir le travail vers les ODD. En savoir plus sur les objectifs de développement durable Net Zero Net zero is a sustainability target that seeks to balance any greenhouse gas emissions with removals or offsets. It involves reducing emissions as much as possible and investing in activities that will absorb an equivalent amount of carbon dioxide or other greenhouse gases from the atmosphere. This helps to ensure that the total impact of human activity on our environment is close to zero. Net zero initiatives are becoming increasingly popular and are seen as a way for businesses to demonstrate their commitment to sustainability. By setting net zero targets, businesses can reduce their carbon footprint and contribute to the global effort of achieving climate neutrality. In addition, such commitments can also help businesses lower costs associated with energy use and bolster their reputation in the marketplace. As countries, businesses, and individuals continue to strive for greater sustainability, Net Zero targets are becoming more commonplace. It is essential that we all take action toward this goal in order to ensure a sustainable future. Learn More We are gladly part of Science Based Targets Race To Zero We Mean Business Coalition Race To Zero Support Patients' Community AcedrA is committed to improving the quality of life in the Middle East and North African region by providing support through patient advocacy groups. We are dedicated to increasing awareness regarding rare diseases and special conditions, as well as connecting patients with medical professionals who can provide the best care for their needs. Our goal is to ensure that all patients receive the treatment they need and have access to the medical support they require. We are passionate about making a difference in people's lives, and we strive to provide our community with the resources needed to lead healthy and fulfilling lives. Discover our Capabilities in Medical Support Support for Scientific Community AcedrA is also strongly committed to education and research, believing that advanced knowledge of rare diseases can open up more treatment options for those affected. We believe that by educating the public about these diseases, more people will be able to make informed decisions about their health and seek the help they need. Our research initiatives are designed to gather data on rare diseases and special conditions in order to develop better strategies for diagnosis, treatment, and management of these conditions. Discover our Capabilities in Medical Support Support for Physically Challenged Persons AcedrA is committed to leveling the playing field and offering everyone the same chances in life, no matter what their physical disability may be. We believe that all individuals have a right to succeed and should be given the chance to do so. We strive to provide physically challenged persons with the ability to work in a safe and supportive environment ensuring that every person has equal access to opportunities regardless of their physical limitations. Discover LIFE@AcedrA We are compliant with "MOWAAMAH " M owaamah is part of the Ministry of Human Resources & Social Development's programs, launched in the implementation of the Strategy for the Rights of Persons with Disabilities. To provide a suitable work environment for persons with disabilities, according to specific criteria & requirements, enabling the enterprise to obtain the necessary license to employ them. MOWAAMAH Outstanding Woman.. Outstanding AcedrA.. At AcedrA, we strive to create a fair and equitable workplace where every employee has the same opportunity for career advancement. We recognize that women often face unique challenges in the professional world and are committed to creating programs that help them develop and thrive in their careers. Our special programs equip women with the tools they need to confidently pursue their ambitions and contribute their talent to our company. We are proud to be an equal opportunity employer and continue to work towards making AcedrA a welcoming place for all genders. We believe that diversity of thought and experience is essential in creating innovative solutions and fostering an environment where everyone can reach their full potential. With this in mind, we are committed to creating programs that provide professional development and support for women, so they can make their mark in the workplace. Discover LIFE@AcedrA Vision 2030 recognizes that a successful, modern nation must encourage and empower all members of society, including women. We adhere to several governmental programs to empower women at work : QURRAH QIYADYAT Philanthropy & Charity We are dedicated to partnering with charitable foundations, initiatives, and programs that align with our values of giving back to our local and global community. Through these partnerships, we are able to assist those in need and help create a better future. AcedrA is passionate about giving back and we are committed to making an impact through our donations, volunteer efforts, advocacy campaigns, and other initiatives. We will continue to strive towards creating a more equitable world for all. Join Us and Enjoy Contributing to the Community We believe in giving back to our community. That's why we are committed to supporting charities that provide care and support for orphans. We invite you to join us in our mission and help make a difference in the lives of these children. E very donation goes a long way, so please consider donating today. Together, we can create a brighter future for these little ones! ENSAN We also participate in medical donation campaigns for international destinations and we are proudly registered within the database of the King Salman Relief Centre Humanitarian Aid and Relief Centre which is striving to become a leading center for relief and humanitarian activities and to transfer the values of the kingdom to the world. King Salman Humanitarian Aid and Relief Centre EKHAA Every day brings new opportunities to be more environmentally responsible, and every action counts. It's up to us to make sure our planet is healthy and thriving. let's do our part! Today Passionné de contribuer à la communauté et à l'environnement. Joignez-vous à nos efforts maintenant! Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Governance Board of Directors

Bonjour Ceci est votre page À propos. C'est une excellente occasion de donner un aperçu complet de qui vous êtes, de ce que vous faites et de ce que votre site Web a à offrir. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager avec les visiteurs du site. Discover our Capabilities +1600 operations Till today AcedrA has succeeded in importing and exporting more than 1600 operations with a Business Success Rate of 98%. In full compliance with international GDP and GSP and local guidelines for importing health products. Discover our Capabilities We deliver Ex cellence AcedrA is an innovative and trusted logistics and distribution partner in the Middle East and North Africa region. With a successful track record of experience, we promise to deliver excellence in all aspects of our supply chain operations. +40,000 patients More than 40 thousand patients took benefits from our medications and devices with a string pharmacovigilance system ensuring good monitoring and avoiding any probability of discontinuation in their treatments. Discover our Capabilities We deliver Care We have developed a comprehensive distribution and supply chain network that ensures our products are available wherever they are needed. Our innovative approach makes sure that we can provide essential healthcare solutions to those who need them most. With AcedrA, you can rest assured that you will always have access to the care you need. +160 customers More than 160 hospitals and healthcare institutions received with an ultimatum level of satisfaction our deliveries. Located on 2 continents, we are a qualified vendor within the most complex organizations either governmental, semi-governmental or private hopistals. Discover our Capabilities We deliver Experience We use cutting-edge technology and specialize in integrating multiple services into a single solution for the convenience and satisfaction of our clients. Whether it's transportation, warehousing, or distribution, AcedrA guarantees an efficient and cost-effective delivery process every time. +30,000,000 units We stored and delivered more than 30 million units with a wide spectrum of galenic forms like injectables, solutions, vials, injection devices, medical equipment, tablets, capsules, powders, syrups, ampoules, tubes, Discover our Capabilities We deliver Expertise ​ AcedrA is the perfect partner to have in your corner when it comes to understanding the complexities of distribution and supply chain management within the Middle East and North Africa region. Our team of experts can help you identify potential risks, create an effective strategy for navigating those challenges, and ensure that your business is well-positioned for success across the region. Contacter Je suis toujours à la recherche de nouvelles opportunités passionnantes. Connectons-nous. info@monsite.com 123-456-7890 Regulatory & Medical Affairs Full Agency Management

Page Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Small Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Small Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Small Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Therapeutic Areas AcedrA Institute

Gouvernance La gouvernance au sein d'AcedrA est d'une importance primordiale. Il est essentiel de maintenir la responsabilité et de protéger les parties prenantes, ainsi que de positionner l'organisation pour le succès futur . Le respect des meilleures pratiques de gouvernance garantit que le conseil d'administration, le conseil de conformité et l'équipe de direction sont responsables des décisions et des actions prises par l'entreprise. Une bonne gouvernance crée un succès commercial à long terme car elle gère les risques et favorise une meilleure prise de décision dans l'ensemble de l'entreprise. L'organigramme Un conseil d'administration et un conseil de conformité en matière de gouvernance devraient être responsables de l'établissement des politiques, de la planification de la relève et de la protection des parties prenantes contre les problèmes ou responsabilités potentiels. Parallèlement à ces responsabilités, les équipes de direction doivent s'assurer que les mesures de gouvernance sont suivies afin d'utiliser efficacement les ressources et de gérer correctement les risques. Avec la gouvernance en place, ces mesures peuvent créer de la transparence et de l'intégrité, favorisant ainsi des relations crédibles avec les parties prenantes externes. ​ Notre conseil consultatif scientifique rassemble des experts de tous les domaines de la science et de la durabilité, nous donnant leur avis professionnel sur l'efficacité de nos projets et initiatives. Cette contribution inestimable nous permet de continuer à proposer des solutions innovantes qui ont des impacts significatifs sur l'écosystème de la santé dans la région MENA. Avec une combinaison de gouvernance et d'un conseil consultatif scientifique, nous sommes en mesure de garder une longueur d'avance sur les défis environnementaux émergents tout en veillant à ce que nos efforts soient fondés sur des pratiques fondées sur des données probantes. Organes de gouvernance d'AcedrA Conseil d'administration Les CA d'AcedrA assurent le leadership et la supervision afin que nous puissions atteindre nos objectifs et réaliser notre mission. Conseil de conformité Conseil quasi-indépendant ayant pour mission de s'assurer de la pleine conformité de l'organisation. Conseil consultatif scientifique Conseil totalement indépendant ayant pour mission de concevoir le parcours scientifque d'AcedrA. Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Our DNA Corporate Social Responsibility

Conseil d'administration d'Acedra Les conseils d'administration d'AcedrA sont chargés de fixer des objectifs et de développer des pratiques éthiques pour assurer la conformité aux réglementations gouvernementales, améliorer le service à la clientèle et favoriser une croissance positive continue de l'entreprise. Les membres du conseil d'administration d'Acedra discutent des stratégies, fixent des objectifs à long terme, fournissent des conseils sur les activités opérationnelles, approuvent les acquisitions et les investissements, identifient les problèmes de personnel clés, autorisent les transactions ou projets majeurs et approuvent les états financiers. Le conseil d'administration d'AcedrA est considéré comme de précieux contrevenants qui relient les administrateurs et la haute direction aux parties prenantes ; créer de la transparence dans la performance de l'entreprise ; rédiger des politiques d'entreprise; surveiller les risques; assurer le respect des lois; processus d'examen; renforcer la confiance des actionnaires ; et stimuler l'innovation. Bkhit Al Dosari Président du Conseil Homme d'affaires expérimenté et ouvert d'esprit avec différentes organisations dans plusieurs secteurs. Membre du conseil d'administration d'une grande entreprise de construction. Hosni STA Fondateur & PDG Pharmacien de formation, entrepreneur avec une expertise régionale dans l'établissement de modèles commerciaux réussis dans les secteurs biotechnologique et pharmaceutique. Mesfer Al Dosari Co-fondateur et directeur général Homme d'affaires avisé avec une grande connaissance des écosystèmes en Arabie Saoudite. Membre du conseil d'administration de plusieurs entreprises dans diverses spécialités. Avez-vous un message à notre BoD, écrivez-nous et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Corporate Social Responsibility Executive Team

Message du PDG Depuis la création d'AcedrA en 2017, nous suivons la règle du « oser faire » dans l'élaboration de nos processus et de nos plans. Nous avons toujours prouvé notre passion pour la science, et c'est dans notre ADN de créer une nouvelle valeur en transformant la façon dont nous aidons les patients et les communautés scientifiques dans cette partie du monde où il existe un écart hétérogène dans la couverture des besoins non satisfaits. Nous avons établi un nouveau modèle d'entreprise qui exige de faire du patient le principal pilier de la formulation d'objectifs d'entreprise durables. Nous avons eu l'audace de prouver notre capacité à servir la communauté scientifique et médicale en créant une plateforme hybride reliant la communauté académique, les entreprises de R&D, les hôpitaux et le patient. Notre présence au Royaume d'Arabie saoudite et notre alignement sur les objectifs de Vision 2030 ont contribué de manière significative à attirer les dernières découvertes scientifiques en termes de solutions pharmacologiques et médicales aux patients et aux communautés scientifiques et ont renforcé notre rôle dans la réduction de l'impact des problèmes non satisfaits. Besoins. Cela nous a aidés à étendre nos activités dans toute la région du Moyen-Orient et de l'Afrique du Nord, car toutes les frontières sont supprimées de la prise en charge de la santé humaine. Et d'opérer dans les nouveaux domaines de la biotechnologie et de l'édition de gènes. Un grand merci du fond du cœur à tous nos collaborateurs, partenaires, bailleurs de fonds, clients. Chaque minute dans l'entreprise est une histoire inspirante pour nous tous sur le dévouement à fournir le meilleur de ce que nous avons pour servir la vision importante et noble. Et la marche continue… vers le succès. Mohamed Hosni STA Fondateur & PDG Al Riyad, Arabie Saoudite 12 janvier 2023 Executive Team Services

Équipe de direction d'AcedrA Notre équipe de direction est composée des membres de l'équipe les plus expérimentés et les plus compétents pour assurer l'atteinte de nos objectifs d'entreprise. Ils sont chargés de prendre les décisions quotidiennes qui façonneront l'orientation générale et la croissance de notre organisation. Nous apprécions les contributions de chaque membre à notre équipe de direction et sommes fiers de leur engagement envers l'excellence ! Hosni STA Fondateur & PDG Pharmacien de formation, avec une maîtrise en gestion de la qualité totale, fusions et acquisitions Executive Education de l'Imperial College de Londres et Management Finance Executive Education de la London School of Economics and Political Sciences Plus de 15 ans d'expertise régionale dans des postes de direction au sein des industries des sciences de la vie. Layla Wahabi Chef de la conformité Ingénieur en biologie industrielle du célèbre Institut National des Sciences Appliquées et de Technologie (INSAT) avec un master en Management de la Qualité Totale. A joué un rôle crucial dans plusieurs sociétés pharmaceutiques locales et multinationales telles que GSK, MSD, Recordati, etc. au sein des départements des affaires réglementaires, des affaires médicales, de l'assurance qualité et de la conformité. De plus, elle a un ToT (Trainer of the Trainers) en compétences générales et managériales. Yamen Natafji Directeur des finances Je suis un paragraphe. Cliquez ici pour ajouter votre propre texte et me modifier. C'est facile. Faten Abou Dan directeur des opérations Je suis un paragraphe. Cliquez ici pour ajouter votre propre texte et me modifier. C'est facile. Alaa Abou Setta Chef des affaires Je suis un paragraphe. Cliquez ici pour ajouter votre propre texte et me modifier. C'est facile. Laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Board of Directors Message from the CEO

AcedrA Pharmacovigilance This form can be used by: Physician Pharmacist D entist Nur ses Other Healthcare Providers ​ Please fill our electronic form with the most accurate info How to report: Fill out the electronic report Attach additional information, if needed Use a separate form for each ADR AcedrA Detection Form Adverse Drug Reactions (ADRs) Reporting Form For Health Care Professionals Date Time Hospital Name Patient Details Patient Name or Initials (Optional) Medical Record No Age Birth Date (Optional) Sexe Male Female Height Weight Date of Starting Treatment Date of Suspected Side Effect Notification Source Address Street Address Line 1 Street Address Line 2 City Region/State/Province Postal / Zip code Country Product Details Supscted Product Drug Vaccine Herbal Cosmetic Other Product Name (Brand) Product Name (Generic) Manufacturer Name Batch Number Expiry Date Dose / Route / Frequency Purpose of Use Additional Products-Concomittant (in case you suspect more than one Product) Adverse Event Adverse event including relevant tests/lab data and dates Other relevant history, including preexisting medical conditions (diagnosis, allergies, pregnancy, hepatic, renal etc) Seriousness of ADR (Tick all applicable) Patient Died Hospitalization Life Threatening Permanent Disability Congenital Anomaly Required Emergency Room (ER) Visit Prolonged hospitalization more than 24 hours Required intervention to prevent permanent impairment/ damage Cancer Others Outcome of ADR (Tick all applicable) * The Patient Recovered Recovering No Improvement Fatal Unknown Event subsided after stopping (dechallenge) No Yes Unknown Event reappear after reintroducing (rechallenge) No Yes Unknown Date of Event Disappeared (If Applicable) Specific antagonist or treatment used: No Yes Prescribing Physician Physician Name Registration Number Position / Specialty Department Country Code Phone Country Code Phone Email Reporter (if different than Prescribing Physician) Reporter Name Registration Number Position / Specialty Department Country Code Phone Country Code Phone Email Please upload any document relevant to this case Upload File Upload supported file (Max 15MB) Please Sign Here Clear I declare that the info I’ve provided is accurate & complete Submit Thanks for submitting! We will review it and revert back to you in less than 24 hours. If you did not receive any feedback from us please call AcedrA Pharmacovigilance Department at +966 11 400 0036 or write directly to SFDA Toll-Free number 8001240411 or +966 11 880 6000 Dear healthcare professional We realize that filling out this form requires time to complete, but reporting adverse drug reactions is indispensable for the safe use of medication. We can judge the safety of our products, promoted or distributed, only if sufficient information is provided. If you would like to use hardcopy instead of the electronic format please download it click here and send it filled and signed by electronic mail to pharmacovigilance@acedrarx.com Confidentiality: The reporter's and patient's identity are held in strict confidence by AcedrA and protected to the fullest extent of the law, information provided by the reporter will be strictly protected and will not be used in any way against him/her. Check below our Specific Privacy Policy Adverse Drug Reaction (ADR) is a response to a medicinal product that is noxious and unintended and which occurs at doses commonly used in man for the prophylaxis, diagnosis or therapy of disease or for the restoration, correction, or modification of physiological function. A serious adverse event or reaction is any untoward medical occurrence at any dose: results in death requires hospitalization or prolongation of existing hospitalization results in persistent or significant disability/incapacity is life-threatening ​ If you would like to report directly to SFDA Vigilance System please click here and download the Guidance on Adverse Drug Events Reporting for Healthcare Professionals ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Privacy Stat ement regarding Pharmacovigilance Data ​ ​ AcedrA Pharmaceutical Company LLC (“AcedrA”) respects your privacy and is committed to protecting your personal data. This Specific Privacy Statement (“Statement”) aims to give you information on how AcedrA collects and processes Personal Data in relation to PV Purposes (defined below) and to tell you about your privacy rights and how the law protects you. It is important that you read this Statement together with any other privacy notice or fair processing notice we may provide on specific occasions when we are collecting or processing personal data abo ut you or others (such as your patients) so that you are fully aware of how and why we are using this data. This PV privacy policy supplements the other notices/statements and is not intended to override them. We have a separate general Privacy Policy which addresses how we handle your data – see our main Privacy Policy here. WHO WE ARE This Statement is issued on behalf of AcedrA Pharmaceutical Company LLC so when we mention ”AcedrA”, “we”, “us” or “our” in this Statement, we are referring to our company, responsible for processing your data. AcedrA is assumed to be the co ntroller of data collec ted under this Statement. If you have any questions about this Statement, includin g any requests to exercise your legal rights, please contact us using the details set out below. ​ A cedrA Pharmaceutical Company LLC Tel : (Toll-Free) 800 12 40 411 (International) +966 11 400 0036 Email: legal.affairs@acedrarx.com or compliance@acedrarx.com You have the right to make a complaint at any time to the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . We would, however, appreciate the opportunity to address your concerns with you before you approach the authorities so please contact us in the first instance. PHARMACOVIGILANCE AcedrA is co—developing, promoting, marketing, and distributing health products for human use (“AcedrA Products”). AcedrA has a legal responsibility to monitor the safety of all of its AcedrA Products in each country regionally where they are supplied. This includes monitoring adverse reactions or events (side effects) associated with the use of the AcedrAl Products which is called Pharmacovigilance (“PV”). PV requirements exist to allow us and competent regulatory authorities (such as the Saudi Food and Drug Authority and Pharmacy & Medicines Department of the Ministry of Health of Tunisia and other regulatory authorities) to collate adverse events, identify new side effects, provide accurate and up to date safety information and ensure continued public health protection . Our PV obligations require us to process certain information, which allows us to directly or indirectly identify a person, (“Personal Data”) of a patient and/or the reporter of an adverse event that we receive in order to comply with strict obligations to perform benefit-/risk assessments of AcedrA Products continuously and report suspected adverse reactions or events to relevant regulatory authorities. This Statement provides important information to you about how we process Personal Data for PV Purposes, in line with our obligations under applicable data privacy laws and in particular the Personal data protection law of Saudi Arabia (Royal Decree No. (M/19) dated 1443/2/9 AH). All Personal Data is processed exclusively for PV Purposes and only where relevant and appropriate to do so in accordance with our PV obligations. WHY DO WE COLLECT PERSONAL DATA In order to meet our PV obligations in respect of the AcedrA Products, we may process Personal Data to: Investigate the adverse event; Contact a patient or their Healthcare Professional for further information about the adverse event being reported; Collate the information about the adverse event with information about other adverse events received by AcedrA to analyze the safety of the AcedrA products or active ingredient, and provide mandatory reports to local competent regulatory authorities so that they can analyze the safety of a production batch, AcedrA Products, generic or active ingredient, (together the “PV Purposes”) Therefore, we process Personal Data, including special categories of Personal Data, in accordance with the Personal data protection law of Saudi Arabia (Royal Decree No. (M/19) dated 1443/2/9 AH) and in order to comply with legal obligations under applicable PV laws and regulations and for its legitimate interests in ensuring the PV Purposes are met. PV law has been issued for reasons of substantial public interest in the area of public health and safety of medicinal products or medical devices. THE DATA WE COLLECT The Personal Data we may need to process (including collecting, storing, or otherwise using and transferring) includes contact data and medical/health data such as the following: I. About the Patient Patient name and/or initials; Date of birth/age group, sex, weight, height; Info rmation about health, racial or ethnic origin, and sexual life; medical history and status, which may for example include: Deta ils of other medicines or remedies you are taking or were taking at the time of the adverse event, including the dosage you have been taking or were prescribed, the period of time you were taking that medicine, the reason you have been taking that medicine and any subsequent change to your regimen; Other medical history considered relevant by the reporter, including documents such as lab reports, medication histories, and patient histories. II. About the Reporter: Name; Contact details (which may include your address, e-mail address, phone number, or fax number); Prof ession (this information may determine the questions you are asked about an adverse event, depending on your assumed level of medical knowledge); and relat ionship with the subject of the report. HOW IS PERSONAL DATA COL LECTED AND USED? We use different methods to collect Personal Data in order to fulfill our PV obligations, these include gathering information received via emails, phone calls, completion of website forms, and regulatory authorities. Personal Data is used solely to enable us to comply with our PV obligations. This means we may use Personal Data by sharing and/or disclosing Personal Data: within AcedrA in order to analyse and process a reported adverse event; with competent regulatory authorities, in respect of a suspected adverse reaction; with third party service providers of AcedrA; these service providers may include safety database providers, call centre operators, and in the event that you disclose details of your suspected adverse reaction to our market researchers, that particular market research provider; with other pharmaceutical companies who are our co-marketing, co-distribution, or other license partners where PV obligations for a AcedrA Products require such exchange of safety information; with a third party successor in business in the event of a sale, assignment or transfer of a specific AcedrA Products; when publishing information about adverse events (such as case studies and summaries); in such cases, we will remove identifiers from any publication to keep an individual’s identity private. We require all third parties to respect the security of Personal Data and to treat it in accordance with the law. We do not allow our third-party service providers to use Personal Data for their own purposes and only permit them to process Personal Data for specified purposes and in accordance with our instructions. We do not sell your Personal Data. INTERNATIONAL TRANSFERS Whilst we do not routinely do so, we may share Personal Data within the companies holding intellectual properties of AcedrA Products. (“Principals”) This will involve transferring your data outside your country. We ensure Personal Data is protected by requiring all our Principals to follow the same rules when processing Personal Data. Most of our Principals are based outside Saudi Arabi, and as a result their processing of Personal Data will involve a transfer of data outside Saudi Arabi. Whenever we transfer Personal Data out of Saudi Arabia, we ensure a similar degree of protection is afforded to it by ensuring at least one of the following safeguards is implemented: we will only transfer Personal Data to a country where there is an applicable data protection regime that such country provides an adequate level of protection for personal data. where we use certain service providers, we may use standard data protection contractual terms recognized or approved under the Saudi applicable data protection regimes. Please contact us if you want further information on the specific mechanism used by us when transferring Personal Data HOW SECURE IS MY DATA? We have put in place appropriate security measures to prevent Personal Data from being accidentally lost, used, or accessed in an unauthorized way, altered or disclosed. In addition, we limit access to Personal Data to those employees, agents, contractors, and other third parties who have a business need to know. They will only process Personal Data on our instructions, and they are subject to a duty of confidentiality. We have put in place procedures to deal with any suspected Personal Data breach and will notify you and any applicable regulator of a breach where we are legally required to do so. HOW LONG WILL YOU USE MY PERSONAL DATA FOR? We will only retain Personal Data for as long as necessary to fulfill the PV Purposes, including for the purposes of satisfying any legal, accounting, or reporting requirements. To determine the appropriate retention period for Personal Data, we consider the amount, nature, and sensitivity of the Personal Data, the potential risk of harm from unauthorized use or disclosure of Personal Data, the purposes for which we process Personal Data and whether we can achieve those purposes through other means, and the applicable legal requirements. For PV-related information, mandatory requirements oblige us to archive PV information which may include Personal Data at least for the duration of the product life-cycle and for an additional ten years after the respective medicinal product has been taken from the market. In some circumstances, we may anonymize Personal Data (so that it can no longer be associated with you) for research or statistical purposes in which case we may use this information indefinitely without further notice to you. YOUR LEGAL RIGHTS Under certain circumstances, you have rights under data privacy and protection laws in relation to your Personal Data. These rights include: Request access to or disclosure of your Personal Data - Commonly known as a data subject access request, this enables you to receive a copy of the Personal Data we hold about you and to check that we are lawfully processing it. You also have a right to know the categories of Personal Data collected, the sources from which Personal Data is collected, our purpose for collection, and the categories of third parties with which Personal Data is shared. Request correction of your Personal Data - This enables you to have any incomplete or inaccurate data we hold about you corrected, though we may need to verify the accuracy of the new data you provide to us. Request erasure of your Personal Data - This enables you to ask us to delete or remove Personal Data from our records where there is no good reason for us continuing to process it and to ask us to direct any third parties to delete Personal Data from their records. You also have the right to ask us to delete or remove your Personal Data where you have successfully exercised your right to object to processing, where we may have processed your information unlawfully, or where we are required to erase your Personal Data to comply with local law. Please note, however, that we may not always be able to comply with your request of erasure for specific legal reasons which will be notified to you, if applicable, at the time of your request. Object to processing of your Personal Data - Where we are relying on a legitimate interest (or those of a third party) and there is something about your particular situation which makes you want to object or opt-out to the processing or disclosure of your Personal Data on this ground as you feel it impacts on your fundamental rights and freedoms, you can do so by contacting us. You also have the right to object where we are processing your Personal Data for direct marketing purposes. In some cases, we may demonstrate that we have compelling legitimate grounds to process your information which override your rights and freedoms. Request restriction of processing your Personal Data - This enables you to ask us to suspend the processing of your Personal Data in the following scenarios: (a) if you want us to establish the data’s accuracy; (b) where our use of the data is unlawful but you do not want us to erase it; (c) where you need us to hold the data even if we no longer require it as you need it to establish, exercise or defend legal claims; or (d) you have objected to our use of your data but we need to verify whether we have overriding legitimate grounds to use it. R equest transfer of your Personal Data to you or a third party - We will provide to you, or a third party you have chosen, your Personal Data in a structured, commonly used, machine-readable format. Note that this right only applies to automated information which you initially provided consent for us to use or where we used the information to perform a contract with you. Right to withdraw consent - Where we are relying on consent to process your Personal Data, you may withdraw it at any time. However, this will not affect the lawfulness of any processing carried out before you withdraw your consent. If you withdraw your consent, we may not be able to provide certain products or services to you. We will advise you if this is the case at the time you withdraw your consent. Protection against discrimination – We will not discriminate against you because you exercised any of the above rights. This means, among other things, we will not deny services to you if you request disclosure or deletion of your Personal Data. HOW TO EXERCISE YOUR RIGHTS If you wish to access your own Personal Data, please contact the Human Resources Director at human.resources@acedrarx.com If you wish to exercise any of the other rights set out above, please contact legal.affairs@acedrarx.com or compliance@acedrarx.com You will not have to pay a fee to access your Personal Data (or to exercise any of the other rights). However, we may charge a reasonable fee if your request is clearly unfounded, repetitive, or excessive. Alternatively, we may refuse to comply with your request in these circumstances. WHAT WE MAY NEED FROM YOU We may need to request specific information from you to help us confirm your identity and ensure your right to access your personal data (or to exercise any of your other rights). This is a security measure to ensure that Personal Data is not disclosed to any person who has no right to receive it. We may also contact you to ask you for further information in relation to your request to speed up our response. Any personal information we collect from you to verify your identity in connection with your request will be used solely for the purposes of verification (unless we notify you otherwise and obtain your approval accordingly). TIME LIMIT TO RESPOND We try to respond to all legitimate requests within one month. Occasionally it may take us longer than a month if your request is particularly complex or you have made a number of requests. In this case, we will notify you and keep you updated. WHERE TO SEEK FURTHER ADVICE If you have any questions regarding this Policy or any related issue, you should contact: Tel: (Toll-Free) 800 124 0411 | (International) +966 11 400 0036 Pharmacovigilance: pharmacovigilance@acedrarx.com Legal Affairs: legal.affairs@acedrarx.com Human Resources: human.resources@acedrarx.com Compliance: compliance@acedrarx.com ​ ​ ​ This policy will be reviewed on September 20th, 2023 Riyadh, Kingdom of Saudi Arabia AcedrA Pharmaceutical Company LLC Compliance Department Pharmacovigilance Legal Affairs

Safe Harbor INTRODUCTION This website and any related websites and applications are proprietary of AcedrA BioPharmaceuticals and covered by the laws of the Kingdom of Saudi Arabia according to the articles of the Saudi Authority for Intellectual Property The content including the media on this website may not be published or distributed without the prior written consent of AcedrA BioPharmaceuticals. ​ FORWARD-LOOKING STATEMENTS This website contains forward-looking statements. These statements relate to future events and involve known and unknown risks, uncertainties, and other factors which may cause our actual results, performance, or achievements to be materially different from any future performances or achievements expressed or implied by the forward-looking statements. Each of these statements is based only on current information, assumptions, and expectations that are inherently subject to change and involve several risks and uncertainties. Forward-looking statements include, but are not limited to, statements about expectations regarding our capitalization and resources; the adequacy of our capital to support our future operations and our ability to successfully initiate and complete commercial operations; our strategy and focus; the development and commercial potential of any of our products; the timing and success of our business development efforts; the success of any of our commercial efforts and our ability to achieve regulatory approval; the entry into or modification or termination of collaborative agreements and the expected milestones and royalties from such collaborative agreements; the potential market or commercial success of the business development programs of AcedrA; and any statements other than statements of historical fact, including those related to AcedrA’s future cash, market or financial position. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,”, “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions (including the negative thereof) intended to identify forward-looking statements. AcedrA may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in any forward-looking statements such as the foregoing, and you should not place undue reliance on such forward-looking statements. The forward-looking statements contained or implied in this presentation are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors“ in AcedrA’s annual reports. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances, or otherwise ​ TRADEMARK DISCLAIMER All trademarks, logos, and brand names mentioned on this website are the property of their respective owners. All company, product, and service names used in this document are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement. ​ AcedrA Board of Directors | AcedrA CEO Department | AcedrA Compliance Department Hotline: (Toll-Free) 8001240411 legal.affairs@acedrarx.com ​ ​ ​

404 Looks like this page no longer exists. Back to Homepage

Les ADN de Acedra Qui nous sommes Créé en octobre 2017 En décembre 2017, AcedrA a obtenu sa licence auprès de la Saudi Food & Drug Authority La vision Soyez la première entreprise complète des sciences de la vie avec des capacités de recherche et de découverte, de fabrication, de développement et de commercialisation visant à faire découvrir et fabriquer le premier médicament à 100 %. Les valeurs Chaque lettre d'AcedrA représente une valeur qui est reflétée par chaque AcedriAian : ​ A pour capacité C pour Compétence E pour Efficacité D comme Dignité R pour Fiabilité et A pour responsabilité La mission Notre mission est de révolutionner l'accès à des solutions de santé innovantes, sûres et efficaces en nous efforçant de créer un environnement de collaboration, d'innovation et de réussite qui favorisera l'abordabilité de traitements et de thérapies révolutionnaires pour les patients et les communautés scientifiques du Moyen-Orient et Région Afrique du Nord. Our Story Governance

Partenariat Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu et assurez-vous d'ajouter tous les détails ou informations pertinents que vous souhaitez partager avec vos visiteurs. Bouton Our Business Units AcedrA is a regional leader in medical innovation, driven by three business units that focus on unmet needs and unique opportunities. Our Unmet Medical Needs business unit specializes in identifying diseases with no available treatments and working to make accessible groundbreaking therapies. The Unmet Commercial Needs unit explores new ways to improve existing methods of care, making treatments more accessible and affordable. Finally, in our Medical Technology unit, we are dedicated to leveraging new technologies to improve patient outcomes and reduce healthcare costs. With advances in all three areas, AcedrA is poised to revolutionize the way medical treatments are delivered around the Middle East & North Africa region. Discover Access Sourcing AcedrA is on a mission to bridge the gap between drug supply and demand, ensuring quality healthcare for all. With our global network of more than 100 suppliers, we are able to provide reliable access to essential medications at competitive prices - breaking down geographical and economic barriers that have previously limited access to treatments. We believe that everyone has a right to quality healthcare! We are committed to making this innovative service available at all times and believe that no one should have to worry about their health due to a lack of access or affordability. With AcedrA, you can put your trust in us for all of your medication needs. Discover Access Innovation AcedrA is revolutionizing the healthcare sector in the MENA region. Bridging with innovative Biotech and MedTech companies, AcedrA aims to reduce the time-to-market for advanced therapeutics and treatments. This translates into a world of possibilities for healthcare professionals, scientific societies, patient communities, and beyond. With access to the latest cutting-edge technology, these individuals and organizations can now stay ahead of the curve, offering enhanced solutions that benefit everyone. AcedrA is making it possible for healthcare professionals to provide better care, and provide patients with access to more advanced treatments. This is a game-changer in the MENA region! Join us as we take healthcare to the next level. Discover Our Therapeutic Areas At AcedrA, we specialize in delivering, distributing, and even co-developing innovative treatments for conditions with unmet medical needs. Our cutting-edge expert team is dedicated to uncovering novel therapeutics that can make life easier for patients across the MENA region who are facing complex cases with limited options. We believe that progress starts here: by taking on today's toughest medical challenges with courage, creativity, and a commitment to excellence. Together, we can make a difference and revolutionize healthcare for everyone. Join us in our mission to provide hope and life-changing solutions. Discover Develop Passionately AcedrA is the go-to partner for Pharmaceutical, Biotech, and Medtech companies in the MENA region looking for value-adding partnerships that will drive their business forward. With AcedrA, you can rest assured that your business development goals will be achieved quickly and efficiently. Business Development AcedrA Institute AcedrA Institute is a comprehensive educational platform that offers healthcare professionals access to the latest news, insights, and research related to the medical field. The platform provides access to curated articles, cutting-edge research studies, and market intelligence from around the world. Our mission is to make sure that healthcare professionals are informed about the latest trends in their field and are equipped to make decisions that can improve patient outcomes. Enjoy Commercial Excellence Business Units

Licence Demander maintenant Prestations de service Ceci est votre page de services. C'est une excellente occasion de fournir des informations sur les services que vous fournissez. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager avec les visiteurs du site. Contact Us Licence Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Programmes gérés et à accès anticipé Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Affaires réglementaires et médicales Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Distribution et chaîne d'approvisionnement Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Gestion complète de l'agence Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Conseil & Consultance Next Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour modifier le contenu et assurez-vous d'ajouter toute information pertinente que vous souhaitez partager avec vos visiteurs. Services personnalisés Ceci est un paragraphe. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer à modifier le contenu. business.development@acedrarx.com Message from the CEO Licensing

Notre travail Ceci est votre page de projet. C'est une excellente occasion d'aider les visiteurs à comprendre le contexte et l'arrière-plan de votre dernier travail. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager. 01 nom du projet Voici la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. 02 nom du projet Voici la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. 03 nom du projet Voici la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. 04 nom du projet Voici la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. We can help you realize your ambitions Let AcedrA be your guide to success. Make the most out of your life sciences venture in the MENA region. Partner with AcedrA Full Agency Management Capabilities

Acedr UN F ROM Cèdre Le nom d'AcedrA vient du nom d'un arbre majestueux "Cèdre", très célèbre au Moyen-Orient et dans la région méditerranéenne. Le grand cèdre sera à jamais profondément enraciné dans les histoires anciennes du monde. De son bois solide et polyvalent à son feuillage persistant parfumé et médicinal, le cèdre a soutenu de nombreux peuples différents avec ses innombrables utilisations pendant des millénaires. Le cèdre est traditionnellement connu pour traiter les maladies difficiles. Ainsi, conçu AcedrA! Notre ADN ! Cliquez ici pour découvrir De l'Arabie Saoudite _cc781905-5cde-3194 au monde entier Depuis sa fondation en 2017, AcedrA a rejoint les efforts du royaume via "Vision 2030" pour renforcer le secteur économique non pétrolier et transformer l'Arabie saoudite en une icône mondiale en termes de recherche scientifique et de développement. ​ L'un des trois principaux piliers de la vision 2030, la création d'une "société dynamique" où permettre une vie pleine et saine grâce à l'amélioration des services de santé et de la qualité de vie dans les villes saoudiennes sont les objectifs stratégiques. Cliquez ici pour en savoir plus sur Vision 2030 Représenter le conseil des actionnaires Conseil d'administration Lire la suite Des experts avisés et dévoués Équipe de direction Lire la suite Construit sur les meilleures pratiques de gouvernance Gouvernance Lire la suite Fait partie de notre politique ESG Responsabilité sociale des entreprises Lire la suite Home Our DNA

APPEL À TOUS LES MÉDIAS Tout ce que tu as besoin de savoir BIOS ET ENTREVUES Convient à tous les médias VIDÉOS DE DÉMO Rendez-le visuel IMAGES ET ICÔNES Les informations dont vous avez besoin Maladies rares et ultra-rares Apprendre encore plus Access Innovation Business Development

Présence régionale Apprendre encore plus Notre Projets Ceci est votre page de projet. C'est une excellente occasion d'aider les visiteurs à comprendre le contexte et l'arrière-plan de votre dernier travail. Double-cliquez sur la zone de texte pour commencer à modifier votre contenu et assurez-vous d'ajouter tous les détails pertinents que vous souhaitez partager. Partner with us nom du projet Voici la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. View More nom du projet Ceci est la description de votre projet. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. View More nom du projet Ceci est la description de votre projet. Fournissez un bref résumé pour aider les visiteurs à comprendre le contexte et l'arrière-plan de votre travail. Cliquez sur "Modifier le texte" ou double-cliquez sur la zone de texte pour commencer. View More Regulatory Support AcedrA is your go-to for Regulatory Support in the MENA region. Our team of experienced professionals provides Regulatory Approval services that are tailored to each need and requirement, allowing them to bring their pharmaceutical & medical products to market quickly and efficiently. View More Business Support With an experienced team of professionals, AcedrA provides tailor-made services that allow clients to optimize their processes and operations. Our solutions are designed to lower costs, improve efficiency, and maximize Return On Investment. View More Enhancing our Capabilities is in our DNA Develop Smartly We are a fast-growing startup with continuous improvement of our capabilities and expanding our footprint. Partner with AcedrA today to live this amazing journey of success! Business Development Advisory & Consultancy Regional Presence

AcedrA Terms & Conditions of Business 1. DEFINITIONS Within these conditions the following definitions shall apply: "AcedrA" shall mean AcedrA Pharmaceutical Company LLC and any AcedrA Subsidiary (as applicable). “AcedrA Subsidiary” shall mean any person that directly or indirectly is controlled by AcedrA Pharmaceutical Company LLC. “Controlled by” shall mean the power to direct or cause the direction of the management or policies of a person whether through the direct or indirect ownership of voting securities, by contract, resolution, regulation, or otherwise. "Deliverables" shall mean all documents, products, and materials developed by the Supplier or its agents, contractors, and employees as part of or in relation to the Services in any form or media. "Intellectual Property Rights" shall mean patents, rights to inventions, copyright and related rights, moral rights, trademarks and service marks, business names, and domain names, rights in get-up and trade dress, goodwill and the right to sue for passing off, rights in designs, rights in computer software, database rights, rights to use, and protect the confidentiality of, confidential information (including know-how and trade secrets), and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted, renewals or extensions of, and rights to claim priority from, such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world. "Order" shall mean the authorized Purchase Order placed by AcedrA upon the Supplier for goods and/or services, including the conditions detailed herein and any authorized amendment thereto. "Products" shall mean all goods to be supplied under the Order, and any replaced or repaired goods provided by the Supplier pursuant to an Order. “Sanctions Laws” means any law, regulation, or wider measure applicable to either AcedrA or the Supplier relating to the adoption, implementation, and enforcement of economic sanctions, export controls, and trade embargos. “Sanctioned Person” means any individual, entity, or body (i) specifically designated under Sanctions Laws, (ii) owned or controlled by any individual, entity, or body specifically designated or listed under Sanctions Laws, or (iii) acting for or on behalf of any individual, entity or body specifically designated or listed under Sanctions Laws. "Services" shall mean all services to be supplied under the Order. "Supplier" shall mean the contracting party on whom the Order is placed. "Working Days" shall mean a day, other than a Friday, Saturday, or public holiday in Saudi Arabia when banks in Saudi Arabia are open for business. And, shall mean a day, other than Saturday, Sunday, or public holiday outside in Saudi Arabia when banks outside Saudi Arabia are open for business. 2. APPLICABLE CONDITIONS These conditions and the Order shall constitute the entire agreement between the parties and shall supersede any prior communications or representations between the parties except that in the event of any conflict between these conditions and the Order and any signed agreement between the parties, the signed agreement shall take precedence. By accepting AcedrA's Order the Supplier agrees that these conditions and the Order supersede any Conditions of Sale issued by the Supplier. All of these conditions shall apply to the supply of both Products and Services except where the application to one or the other is specified. 3. OFFICIAL ORDER No Products or Services will be accepted or paid for unless supplied in accordance with the Order. The Supplier shall reference the Order number on all correspondence entered into. Within 2 Working Days of the Order being issued, the Supplier shall sign and return a copy of the Order to confirm its acceptance. Failure to comply will result in the Order being deemed as accepted. The Supplier shall not deliver the Products in installments without AcedrA's prior written consent. Prior to accepting the Order, the Supplier will inform AcedrA if the Products must be delivered in installments and AcedrA can consent at its discretion. Where it is agreed that the Products are to be delivered in installments, they may be invoiced and paid for separately. 4. AMENDMENTS Prior to acceptance of the Order by the Supplier in accordance with clause 3, AcedrA may amend or withdraw its Order at any time. Once accepted, no variation to the Order will be recognized by AcedrA unless presented in writing and duly authorized by AcedrA in writing. 5. SPECIFICATION Once an Order is accepted by the Supplier in accordance with clause 3, all Products or Services under each Order shall conform where applicable with the quantity, quality, standard, and specification stated on the Order. All Products shall comply with all applicable statutory and regulatory requirements relating to the manufacture of the Products and shall be of satisfactory quality (within the meaning of the Saudi Food and Drug Authority Clearance Conditions & Requirements 2015 , as amended) and fit for the purpose made known to the Supplier by AcedrA expressly or by implication and free from defect whether actual or latent. Where the Supplier has provided AcedrA with a sample of the Products, the Products delivered will be of the same quality as the sample and be without defect. All Products must comply with Saudi Food and Drug Authority Regulatory Framework for Drugs Approval 2020 in order to minimize the risk of transmitting animal spongiform encephalopathy via Medical Products. All New Products ordered by AcedrA require documentation from the manufacturer confirming compliance with the Saudi Food and Drug Authority Clearance Conditions & Requirements 2015. All Products must have at least Sixty Seven Percent (67%) (2/3) of shelf life remaining as of the date of delivery to AcedrA. Failure to comply will result in non-payment unless a prior agreement has been reached with AcedrA. In the event of a product recall, the Supplier shall reimburse AcedrA for all reasonable expenses incurred in carrying out the recall. In providing the Services, the Supplier shall co-operate with and comply with all instructions of AcedrA, including requirements in the Order, and will perform the Services with the best care, skill, and diligence in accordance with best practice in the Supplier's industry, profession or trade. The Supplier shall use personnel who are suitably skilled and experienced to perform tasks assigned to them, and in sufficient numbers to ensure that the Supplier's obligations are fulfilled in accordance with the Order. 6. PACKAGING All Products under the Order shall be securely and adequately packed, and the packaging marked with AcedrA's Order number. All packaging shall be non-chargeable and non-returnable unless otherwise agreed in writing by AcedrA whereupon it may be returned at the Supplier's risk and expense. 7. DELIVERY AND PERFORMANCE Delivery shall be strictly in accordance with the instructions detailed on the Order, including the date of delivery, and shall be at the risk of the Supplier. Delivery shall be made to the delivery address detailed on the Order during the following times unless agreed otherwise by the parties: -Sunday to Thursday - 8.00 a.m. to 4.00 p.m. (Delivery Location Time) in the delivery location in Saudi Arabia. For outside Saudi Arabia (Tunisia, United Arab Emirates, and Egypt) delivery times: -Monday to Friday - 8.00 a.m. to 4.00 p.m. (Delivery Location Time) in the delivery location. Each delivery of the Products should be accompanied by a delivery note that quotes the Order number. Where the Products are being delivered in installments, the delivery note must identify this along with the outstanding balance of Products remaining to be delivered. All temperature-sensitive Products must be clearly labeled to identify them as such and transported within the manufacturer's required storage temperature parameters. If for whatever reason delivery is not affected in accordance with the Order, then AcedrA may, without prejudice to any other right or remedy, wholly or partially terminate the Order without incurring liability to the Supplier. The Supplier shall meet any performance dates for the Services specified in the Order or that AcedrA notifies the Supplier. Title in the Products shall pass to AcedrA on the unloading of the Products at the delivery address detailed on the Order (or for international orders at the import terminal prior to customs clearance). Such passing of title shall not constitute acceptance of the Products. In the event of AcedrA being unable to accept deliveries, for whatever reason, AcedrA shall have the right to suspend, wholly or in part, deliveries under the Order. 8. INSPECTION AND REJECTION AcedrA shall have the right to inspect the Products when delivered and to review the Services. If the Products are not delivered on the delivery date identified in the Order, or if the Products and/or Services do not conform with the Order or do not comply with clause 5 of these conditions, then, without limiting any of its other rights or remedies, and whether it has accepted the Products or Services, AcedrA may: reject the Products or Services (in whole or in part) and return them to the Supplier at the Supplier's own risk and expense. Any Products or Services rejected shall be deemed as not having been delivered or performed; require the Supplier to repair or replace the rejected Products, to provide repeat performance of the Services, or to provide a full refund of the price of the rejected Products or Services; recover from the Supplier any costs incurred by AcedrA in obtaining substitute goods or services from a third party; and claim damages for any other costs, loss, or expenses incurred by AcedrA which are in any way attributable to the Supplier's failure to carry out its obligations. 9. PRICE Prices shall be as stated on the face of the Order and unless agreed otherwise shall be exclusive of Value Added Tax or similar tax and customs duties which if applicable shall be payable by AcedrA in addition to the Price at the rate in force under the applicable law. No alterations will be accepted unless by prior written agreement from AcedrA. Prices shall include costs of packaging, insurance, and carriage of the Products and include every cost and expense of the Supplier directly or indirectly incurred in connection with the performance of the Services. 10. INVOICES AND PAYMENT Invoices quoting the Order number, description, and quantity of Products delivered or Services provided shall be forwarded at the time of dispatch or after the completion of the Services to the relevant address as advised by AcedrA. Failure to detail any of the above information may result in a delay in payment by AcedrA. Unless otherwise stated in the Order, payment will normally be made in the month following the month in which the Products or Services in accordance with the Order, and a correct invoice, are received. 11. INDEMNITY In respect of the Order, the Supplier hereby agrees to indemnify and hold harmless AcedrA against all claims, damages, liabilities, and costs (including but not limited to any direct, indirect, or consequential losses, loss of profit, loss of reputation, and all interest, penalties and legal costs (calculated on a full indemnity basis) and all other reasonable professional costs and expenses) suffered or incurred by AcedrA resulting from: any damage, loss, death, or injury caused by an act, negligence, or omission arising out of or in connection with defects in Products or Deliverables, to the extent that the defects in the Products and Deliverables are attributable to the acts or omissions of the Supplier, its employees, agents or its subcontractors; any defect in or damage to the Products caused by or contributed to by the Supplier; any alleged or actual infringement of any Intellectual Property Rights in existence or pending at the date of the Order relating to the manufacture, supply, or use of the Products, or receipt, use, or supply of the Services and Deliverables; and any breach of Sanctions Laws. This clause shall survive the termination of an Order. 12. ASSIGNMENT The Supplier hereby agrees that no work in pursuance of the Order shall be assigned without the prior written consent of AcedrA. 13. CONFIDENTIALITY All confidential information associated with the Order, including confidential information concerning the business, affairs, customers, clients, or suppliers of the other party, shall be treated as strictly confidential between AcedrA and the Supplier. 14. PARTIAL INVALIDITY AND WAIVER Any provision of the Order subsequently found to be invalid shall not in any way affect the validity or enforceability of the remainder of the Order. Any failure by either party to enforce any provision of the Order shall not be construed as a waiver of that or any other provision. 15. NOTICES Any Notice or other communication entered into shall be in writing and addressed to the Supplier if notices are being given to the Supplier, or to the AcedrA entity named in the Order if notices are being given to AcedrA. 16. INTELLECTUAL PROPERTY All Intellectual Property Rights in Deliverables or arising out of or in connection with the Services (other than Intellectual Property Rights in any materials in the Deliverables that were owned by the Supplier prior to providing the Services ("Background IP") shall be owned by AcedrA unless agreed otherwise between the parties. The Supplier hereby assigns to AcedrA or shall procure the assignment to AcedrA of, all rights, title, and interest in the Deliverables (except to the Background IP) anywhere in the world. The Supplier hereby grants AcedrA a fully paid-up, non-exclusive, royalty-free, irrevocable, and perpetual license to use, modify and publish the Background IP to the extent it is incorporated in the Deliverables so that AcedrA may use the Deliverables in any way it wishes. AcedrA grants the Supplier a fully paid-up, non-exclusive, royalty-free non-transferable license to copy and modify any materials provided by AcedrA to the Supplier for the term of the Order for the purpose of providing the Services to AcedrA. 17. TERMINATION For Convenience- AcedrA shall have the right to terminate the Order in whole or part, at any time before delivery of the Products or completion of the Services, by serving on the Supplier written notice of termination. Upon receipt of such notice of termination, all terminated work shall be discontinued and AcedrA shall pay to the Supplier such sum as is fair and reasonable in respect of any direct loss sustained by the Supplier by reason solely of such termination and the Supplier agrees to accept such sum in full and final satisfaction of all claims arising out of such termination. In the event of termination of the Order, the Supplier shall use its best endeavors to mitigate the loss arising from such termination. In no case shall the amount payable by AcedrA for the terminated Services or Products exceed the price that would have been payable if the Services had been completed or the Products delivered. For Default- AcedrA shall notify the Supplier of any breach or default of these conditions. If the Supplier is unable to remedy such breach or default within a period of 30 days from the notice being given, then AcedrA reserves the right to terminate the Order in whole or part without incurring liability to the Supplier. For Insolvency- In the event that the Supplier becomes insolvent then AcedrA reserves the right to suspend or terminate the Order without incurring liability to the Supplier. Termination of an Order, however arising, shall not affect any of the parties rights and remedies that have accrued as at termination, including the right to claim damages in respect of any breach of these conditions which existed at or before the date of termination. 18. FORCE MAJEURE Neither party shall be in breach nor liable for delay in performing, or failure to perform, any of its obligations under these conditions if such delay or failure results from events, circumstances, or causes beyond its reasonable control. In such circumstances, the affected party shall be entitled to a reasonable extension of the time for performing such obligations. If the period of delay or non-performance continues for 2 weeks, the party not affected may terminate the Order immediately by giving written notice to the affected party. 19. DATA PRIVACY Where AcedrA processes your personal data in relation to the purchase of Products or Services under the Order we will comply with any applicable data protection legislation currently in force, including but not limited to governed by the Personal data protection law (Royal Decree No. (M/19) dated 1443/2/9 AH) , the Main Principles of Personal Information Protection, and the Main Principles and General Rules for Sharing Data issued by the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . and any national implementing laws, regulations, and secondary legislation, as amended or updated from time to time and any successor legislation thereto. 20. ANTI-BRIBERY AND CORRUPTION Both AcedrA and the Supplier shall not, and shall procure that their respective directors and employees shall not, engage in any activity, practice, or conduct which would constitute an offense under any anti-bribery and anti-corruption laws, regulations, and codes in any jurisdiction, including but not limited to the Anti-Money Laundry of Saudi Arabia 20217 the UK Bribery Act 2010 and, where applicable, the US Foreign Corrupt Practices Act 1977 . 21. MODERN SLAVERY Each party shall and shall procure (where relevant) that all persons who are performing services or providing goods in connection with, or which will or may be used in performing or to support the performance of these conditions in any part of the world (collectively, its "Supply Chain") shall at all relevant times (a) comply with the provisions of Anti-Trafficking in Persons Law Royal Decree no. M/40, dated 21/7/1430H ; (b) not engage in any activity, practice, or conduct that would constitute an offense under the Anti-Trafficking and Modern Slavery Statement of AcedrA if such activity, practice, or conduct were carried out in the Kingdom of Saudi Arabia; and (c) take all reasonable steps to ensure that slavery and human trafficking are not taking place in its business or its Supply Chain. 22. SANCTIONS The Supplier and AcedrA acknowledge the existence of Sanctions Laws and shall ensure that they comply with all applicable Sanctions Laws to which either the Supplier or AcedrA is subject, including those of any jurisdiction where either the Supplier or AcedrA are located or incorporated. The Supplier and AcedrA shall not take any action or refrain from taking any action which would, or would in the reasonable opinion of the party subject to Sanctions Laws, cause the such party to breach such Sanctions Laws. The Supplier shall carry out appropriate due diligence with regard to any third party involved in the supply of the Products and Services. The Supplier shall ensure that it has no knowledge or reasonable cause to suspect that any activities relating to the Products or Services will, either directly or indirectly, involve any Sanctioned Person or will otherwise be in breach of Sanctions Laws. In the event of either party becoming a Sanctioned Person, the other party may terminate any Orders with immediate effect and without payment of compensation. 23. APPLICABLE LAW This Agreement and any Order shall be subject to and interpreted in accordance with the Laws of the Kingdom of Saudi Arabia and the Supplier hereby submits to the jurisdiction of the Saudi Courts. AcedrA T&Cs of Sales 1. DEFINITIONS In these terms and conditions (“T&Cs”), the following definitions shall apply: “Clinical Trial Products” means any products ordered from Us by You including without limitation pharmaceutical compounds and drugs, medical equipment, and medical supplies which are ordered by You for use strictly in connection with any clinical trial; “AcedrA Subsidiary” means any person that directly or indirectly is controlled by AcedrA Pharmaceutical Company LLC; “Contract” means any contract between You and Us incorporating these T&Cs for the sale of Products and/or the provision of the Services; “controlled by” means the power to direct or cause the direction of the management or policies of a person whether through the direct or indirect ownership of voting securities, by contract, resolution, regulation, or otherwise; “Field of Use” means the field of use and/or application for which You have engaged Us to perform the Services as stated in the Quotation where provided by Us and agreed by You or as otherwise agreed by Us and You in writing in an order placed by You and accepted by Us; “General Products” means any products ordered from Us by You including without limitation pharmaceutical compounds and drugs, medical equipment and medical supplies, and any ancillary Services required, but excluding the Clinical Trial Products; “Liability” means liability for any and all damages, claims, proceedings, actions, awards, expenses, costs, and any other losses and/or liabilities; "Order" means Your purchase order form, or Your written acceptance of Our Quotation, as the case may be; “Products” means General Products and Clinical Trial Products; “Quotation” means, where provided by Us, the form completed and signed by Us and You, confirming the price for the Products and Services and other variable details specific to your order; “Sanctions Laws” means any law, regulation, or wider measure applicable to either You or Us relating to the adoption, implementation, and enforcement of economic sanctions, export controls, and trade embargos; “Sanctioned Person” means any individual, entity, or body (i) specifically designated under Sanctions Laws, (ii) owned or controlled by any individual, entity, or body specifically designated or listed under Sanctions Laws, or (iii) acting for or on behalf of any individual, entity or body specifically designated or listed under Sanctions Laws; “Services” means without limitation the sourcing, procurement, and/or distribution of medicinal products, comparator drugs, other health products, medical supplies, and equipment, and managed access, clinical trials, pharmaceutical, clinical consultancy and advisory services, and/or work; “We, Us, Our” means AcedrA Pharmaceutical Company LLC or any AcedrA Subsidiary; “You, Your, Yourself” means the person, organization, or other business entity whose order for Products and/or Services is accepted by Us and to whom We subsequently supply the Products and/or Services. 2. BASIS OF CONTRACT AND QUOTATIONS 2.1 These T&Cs shall govern the agreement between You and Us to the exclusion of any other terms or conditions, including the exclusion of any terms or conditions which You may purport to apply under any purchase order, confirmation order, or similar document except that in the event of any conflict between these T&Cs and any signed agreement between You and Us the signed agreement shall take precedence. 2.2 No oral warranties or representations shall bind Us. No variation of these T&Cs shall be binding on Us unless agreed in writing between You and one of Our authorized representatives or contained in the relevant Quotation where provided by Us. Our employees, sub-contractors, and/or agents are not authorized to make any representations or warranties concerning the Products and/or Services unless confirmed by Us in writing. You acknowledge that You do not rely on any representation and/or warranty that has not been made in accordance with these T&Cs. 2.3 Quotations will not form part of the Contract unless accepted by signature by both You and Us within the time period specified on the Quotation ("Quotation Offer Period"). Quotations may be withdrawn by Us at any time during the Quotation Offer Period by oral or written notice. Notwithstanding this, We shall have the right to refuse to accept any orders placed for Products and/or Services under the Quotation. 2.4 All of these T&Cs shall apply to the supply of both Products and Services except where application to one or the other is specified. 3. Orders 3.1 The Contract between You and Us shall come into effect on Our acceptance of Your Order. No Order shall be deemed accepted by Us until confirmed in writing by Our authorized representatives. 3.2 You shall be responsible for the accuracy of an Order and for giving Us any information necessary to perform the Contract. 3.3 If You approve sample Products supplied by Us then You shall have no claim in respect of, nor any right to reject, the Products, provided those Products are of the same description, specification, quality, and fitness for purpose as the sample. 4. Delivery and performance 4.1 We shall deliver the Products to the location set out in the Order or such other location as the parties may agree ("Delivery Location"). We will use Our reasonable commercial endeavors to ensure delivery and/or performance on the dates specified in the Order, but dates for delivery and/or performance are estimates only and are not guaranteed. Time is not of the essence in relation to such dates and late delivery or perfor mance shall not entitle You to cancel the Order. They are also subject to any matter beyond Our reasonable control. 4.2 Delivery shall be deemed to occur: 4.2.1 where Products are delivered by Us to You: at the time when the Products arrive at the Delivery Location; or 4.2.2 where Products are collected by You: on collection from the designated collection address and in any event, no later than 3 Working Days after You have been notified that the Products are available for collection in accordance with clause 4.9. 4.3 Where we require the return of any packaging material, You shall make any such packaging materials availa ble for collection at such times as We shall reasonably request. Returns of packaging materials shall be at Our expense. 4.4 If Products are to be delivered in installments , each delivery shall constitute a separate and distinct contract. Failure by Us to deliver, or a claim by You regarding, any installment under a separate and distinct contract shall not entitle You to repudiate and/or terminate the Contract as a whole or any other separate and distinct contract or Order. 4.5 Where Services are to be performed in stages, each stage shall constitute a separate and distinct contract. Failure by Us to deliver or any claim by You in respect of, any stage under a separate and distinct contract shall not entitle You to repudiate and/or terminate the Contract as a whole or any other separate and distinct contract or Order. 4.6 We shall not be required to fulfill Orders for Products and/or Services in the sequence in which they are placed. 4.7 You shall procure during normal working hours that We have free rights of access to the Delivery Location or the relevant location to perform the Services. You shall be responsible at Your own cost for all arrangements to unload the Products when delivered to You. Unless otherwise agreed in writing, delivery of Products and performance of Services will be made between 0800 hours and 1700 hours, Sunday to Thursday, excluding public holidays in Saudi Arabia and the country of the Delivery Location (“Working Days”). 4.8 If You fail or refuse to t ake delivery of any Products and/or to allow performance of the Services then We shall be entitled to withhold delivery and/or performance of those Products and/or Services and to treat the Contract for that particular Order as repudiated by You. If any delay to take delivery of any Products is caused by You, We may store the Products for at least 7 Working Days in accordance with clause 4.9, and charge You for all related costs and expenses (including insurance). 4.9 If We agree that the Products are to be collected from Us by You then You shall collect the Products within 3 Working Days of being notified that the Products are ready for collection. If the Products are not collected by You within this tim e We may store the Products at Your expense and risk until collection. 4.10 If after 7 Working Days, you do not rectify the failure or refusal to take delivery of Products or to allow performance of the Services under clause 4.9, or You do not collect the Products from Us within the time period specified in clause 4.9, We may in Our discretion sell or otherwise dispose of part or all of the Products and will no longer make the Services available to you. 4.11 Where the quantity of Products delivered is not in accordance with the Order, You must notify Us within 3 working days of delivery or within 1 day of delivery in relation to cell therapy or gene therapy Products. We will remedy any shortfall in delivery where We consider an error in the order has occurred solely by Us. 4.12 If We accept that any Services we have supplied have not been supplied in accordance with the Contract We will perform such Services again so that they are in accordance with the Contract. 5. Damaged and Defective Products 5.1 Any Products which are alleged to be defective or damaged must be notified to Us within 5 Working Days of delivery or collection, or within 1 day of delivery or collection in relation to cell therapy or gene therapy Products, with a written report of the alleged defect or damage, and where reasonable and if requested by Us be returned to Us within 10 Working Days of the date of delivery or collection in their original boxes and packaging for inspection. We will alert the Product manufacturer as quickly as reasonably possible and: 5.1.1. if the Products are confirmed as being defective then a credit for the price of the defective Products or replacement will only be issued by Us as authorized by the manufacturer concerned, and whichever option is provided is at the discretion of the manufacturer and/or Us; and 5.1.2. if the Products are confirmed as being damaged then either a refund or credit will be offered to You at Our discretion. 5.2 We will not accept Product returns except solely where agreed by Us in accordance with these T&Cs or in relation to a Product recall. 5.3 If, after the time periods referred to in clause 5.1 have passed and You have not raised any allegations of defective or damaged Products, You are deemed to have accepted the Products. 6. Postponement and Cancellatio n 6.1 We may comply with reasonable requests by You for postponement of delivery and/or performance but shall be under no obligation to do so. Where delivery and/or performance is postponed at Your request and We have agreed to that postponement, then We may require that You pay all Our costs and expenses incurred as a result including, but not limited to, reasonable charges for storage, transportation, and insurance. In addition, You shall be obliged to pay for the Products and/or Services in accordance with clause 7 as if delivery and/or performance had not been postponed. 6.2 If You wish to cancel an Order which has been accepted by Us, you must notify us immediately. Except where cancellation occurs in accordance with clause 8.1, at Our discretion, we may agree to the cancellation of the Order and termination of the relevant Contract. Our agreement to terminate the Contract for that Order will only be effective upon one of Our authorized representatives agreeing to it in writing. Notwithstanding our acceptance of a cancellation, We may require in Our discretion that You indemnify Us in full against all loss (including loss of profit), costs (including the cost of all labor and materials used), damages, charges, and expenses incurred by Us as a result of cancellation. 6.3 If you purport to cancel an Order without our consent an d/or refuse to accept delivery of ordered Products and/or the performance of any ordered Services You will: 6.3.1 have no further recourse against Us under the Contract; and 6.3.2 indemnify and keep Us indemnified against any and all lost profits, costs (including increased administration costs and legal costs on a full indemnity basis), expenses, damages, and any other loss and/or Liability suffered by Us as a result. 7. Price, Payment, and Credit Limit 7.1 The price of the Products and/or the Services shall be as specified in the Quotation or where no Quotation is signed by Us and You, as otherwise specified in writing by Our authorized representatives and confirmed in a written order. Except as otherwise stated, prices are exclusive of any transport, packaging, and/or insurance costs and are exclusive of any applicable taxes and duties for which You shall additionally be liable. 7.2 Where any taxable supply for Value Added Tax or similar tax purposes is made under the Contract by Us to You, You shall, on receipt of an invoice from Us, pay to Us such additional amounts in respect of such Value Added Tax or similar tax as are chargeable on the supply of the Services or Products at the same time as payment is due for the supply of the Services or Products. 7.3 We may increase Our prices where an increase in costs, expenses, and/or materials is suffered by Us (including, without limitation, any factor outside of Our control such as any foreign exchange fluctuation, currency regulation, and alteration of duties). You will be informed in advance and in writing by Us of any price increases for the Products and/or the Services as soon as practicable after we become aware of any changes. You may cancel without Liability any Contract in relation to which the price is to be increased, provided that the notice of cancellation is received by Us before the change becomes effective. 7.4 If Y ou do not cancel the Contract for the provision of the Products and/or Services before the price increase becomes effective then the price increase shall take effect for the Products and/or Services ordered by You. 7.5 Unless otherwise agreed in writing by Us or specified in the Quotation: 7.5.1 Our terms of payment are 30 days from the date of invoice; 7.5. 2 time for payment shall be of the essence; 7.5.3 all invoices issued on a pro-forma basis are due for immediate payment; and 7.5.4 payment of a n invoice shall be in full and in cleared funds to a bank account nominated in writing by Us. 7.6 If You fail to make any payment in full on the due date then, without prejudice to any other right or remedy available, We may charge You any reasonable additional administration costs and/or interest (both before and after judgment) on the amount unpaid at the rate of 4% per annum above the base rate from time to time of Our bank. 7.7 We may invoice each delivery of Products and/or stage of the Services separately. We will render an invoice to You at any time and/or at any stage during the performance of the Contract. 7.8 You shall pay all sums due to Us without any set-off, deduction, counterclaim, and/or any other withholding. Payment shall not be deemed to be made until We have received either cash or cleared funds in respect of the full amount outstanding. 7.9 If payment in full is not made to Us when due then We may withhold or suspend future or current deliveries of the Products and/or performance of the Services and delivery and/or performance under any other agreement with You and/or cancel the Contract. 7.10 If any Services are canceled, the Contract is terminated, or delivery and/or performance is suspended before the completion of the Services, We are entitled to be paid on a quantum meruit basis for that part of the Services performed. We may invoice You accordingly and such monies shall be due for payment in accordance with clause 7.5. 7.11 We may set a reasonable credit limit for You. We may refuse to accept orders for Products and/or Services and/or suspend or withhold delivery of Products and/or Services if such Products and/or Services would result in You exceeding or you have exceeded Your credit limit. ​ 8. Specification, Intellectual Property Rights, and Confidentiality 8.1 Specifications supplied by Us to You shall only be approximate unless stated in the Quotation or otherwise agreed in writing. If there is an error in the specification made by Us in the Quotation or as otherwise agreed in writing by Us, where that error is material and it has been relied upon by You, You may cancel that part of the Contract only which is affected by the error without Liability due to the cancellation in respect of that part canceled. 8.2 The quantity, quality, description, and/or specification for the Products and/or the Services shall be that set out in Your Order. You are responsible for checking the Order and satisfying Yourself that any specification given is accurate and adequate for the Products and/or Services. 8.3 We shall have no liability for errors in any specification or details supplied by You. We will use all reasonable endeavors to provide final products to the same specification as proofs or samples, however, no guarantee is expressed or implied that the entire consignment of Products will have the same specification as the sample. 8.4 We warrant that, where Products are supplied by description and not sample, on delivery, the Products will comply with their description in the Order in all material respects. We warrant that the Services will be provided using reasonable care and skill. 8.5 You shall not make any modification to the Products or their packaging, nor alter, remove, or tamper with any trademarks used on or in relation to the Products and/or Services. All intellectual property rights (including without limitation all patents, copyright, design rights (whether registered or unregistered), trademarks (whether registered or unregistered) skill and/or know-how, and other similar rights, whether existing now and/or in the future, wherever existing in the world together with the right to apply for protection of the same): 8.5.1 in the Products and/or their packaging shall be owned by Us or the relevant manufacturer (as appropriate) absolutely; 8.5.2 arising from the Services shall be owned by Us absolutely (excluding materials provided by You to Us in order to perform the Services). 8.6 You will at Our cost and request, do all acts and/or things and execute all documents and/or deeds to give effect to clause 8.5 above and/or to assist Us in the application, registration, renewal, and/or protection of such intellectual property rights. 8.7 We reserve absolutely all rights to be identified as the authors of any works arising and/or generated from the Services in accordance Saudi Authority for Intellectual Property . We may utilize for the benefit of Our other customers any skill and/or know-how developed and/or acquired in the performance of the Services. 8.8 We grant to You a non-exclusive royalty-free license to use within the Field of Use all intellectual property rights owned by Us which arise solely from the Services except that We shall be entitled to use such intellectual property rights inside and outside of the Field of Use for ourselves and for con ducting other research and/or projects for Our other customers. All rights and licenses not specifically and expressly granted to and conferred upon You by the Contract are for all purposes reserved to Us. 8.9 We may terminate the license granted under clause 8.8 at any time with immediate effect upon notice if any of the events in clause 10.2 occur in relation to You and/or if You use, attempt to use, and/or We reasonably suspect that you intend to use the intellectual property rights (specified in clause 8.5) arising from the Services otherwise than in accordance with the Contract. 8.10 You grant to Us a fully paid-up, non-exclusive, royalty-free license to copy and modify any materials provided by You to Us for the term of the Contract for the purpose of providing the Services. 8.11 Each party undertakes that it shall not at any time during the Contract, and for a period of five years after termination or expiry of the Contract, disclose to any person any confidential information concerning the business, affairs, customers, clients or suppliers of the other party, except as permitted by clause 8.12. 8.12 Each party may disclose the other party's confidential information: 8.12.1 to its employees, officers, representatives, contractors or subcontracts, or advisers who need to know such information for the purposes of exercising the party's rights or carrying out its obligations under or in connection with the Contract. Each party shall ensure that its employees, officers, representatives, or advisers to whom it discloses the other party's confidential information comply with this Clause 8; and 8.12.2 as may be required by law, a court of competent jurisdiction, or any governmental or regulatory authority. 8.13 No party shall use any other party's confidential information for any purpose other than to exercise its rights and perform its obligations under or in connection with the Contract. 9. Property and Risk 9.1 Risk in the General Products under an Order shall pass to You at the time of delivery as identified in clause 4.2. 9.2 We shall retain the title of the General Products under an Order until We have received payment in full in cash or cleared funds of all sums due and/or owing in relation to those General Products. 9.3 Until We have received full payment for General Products supplied to You, You shall store the General Products separately from any products or goods belonging to You or any third party and the General Products must be clearly identified as being Our property. You agree that Our employees and/or agents shall be entitled to enter Your premises to check compliance with this clause, and You agree to provide them with access. You shall properly store and protect the General Products and keep the General Products insured for the price at which the General Products were sold to You against all insurable risks and shall hold any proceeds of such policy of insurance relating to the General Products on trust for Us and account to Us for any proceeds of such policy of insurance relating to the General Products upon receipt of the same. Any monies received from You by Us in accordance with this clause shall not discharge Your liability to pay the price for the General Products plus interest accrued in accordance with clause 7.6 but shall be set off against such liability. 9.4 In the event that there is no payment due for the General Products provided by Us to You, the title shall pass to You at the time of delivery as defined in clause 4.2. 9.5 Title to the Clinical Trial Products and liability for risk of loss or damage shall pass from Us to You immediately after We have purchased and ourselves acquired title to the relevant Clinical Trial Products. You shall be responsible for arranging insurance in respect of the Clinical Trial Products immediately after We have purchased the relevant Clinical Trial Products. We shall only be liable for any damage caused to the Clinical Trial Products, on a contractual or non-contractual basis, to the extent that such damage is caused by Our wilful misconduct or recklessness. 10. Termination and Default 10.1 Without affecting any other right or remedy available to it, either party may terminate a Contract by giving the other party not less than 12 months' written notice. 10.2 If You:- 10.2.1 fail to make payment to Us when due; 10.2.2 breach the terms of the Contract and, if capable of remedy, have not remedied the breach within 10 Working Days of receiving notice requiring it to be remedied; 10.2.3 persistently breach any one or more terms of the Contract; 10.2.4 pledge or charge any Products which remain Our property, or cease or threaten to cease to carry on business, or propose to compound with Your creditors, apply for an interim order under Section 252 Insolvency Act 1986 or have a Bankruptcy Petition presented against You, enter into voluntary or compulsory liquidation, have a receiver, administrator or administrative receiver appointed over all or any of Your assets, or take or suffer any similar action in any jurisdiction; 10.2.5 appear from Your credit rating to be financially unable to meet Your obligations under the contract; and/or 10.2.6 appear reasonably to Us to be about to suffer any of the events described in 10.2.4 and 10.2.5; then We shall have the right, without prejudice to any other remedies, to exercise any or all of the rights set out in clause 10.3. 10.3 If any of the events in clause 10.2 occur in relation to You then:- 10.3.1 We may enter, without prior notice, and You shall give us access to, any of Your premises (or premises of third parties, of which You shall procure that We are given access to) where Products owned by Us may be and repossess and dispose of or sell any Products found which are owned by Us so as to discharge any sums due to Us under this Contract or any other agreement with You; 10.3.2 We may require You not to re-sell or part with the possession of any Products owned by Us until You have paid in full all sums due to Us under the Contract or any other agreement; 10.3.3 We may withhold delivery of any undelivered Products and/or performance of any Services and stop any Products in transit and/or cease any Services in progress; 10.3.4 We may cancel, terminate and/or suspend without Liability to You any agreement with You; and/or 10.3.5 All monies owed by You to Us shall become due and payable immediately. 10.4 Additionally, if any of the events in clauses 10.2.4 – 10.2.6 occurs in relation to You, We shall have a lien over all property or goods belonging to You in Our possession in respect of all sums due from You to Us, and upon the termination of the Contract if monies due to Us from You have not been paid within 7 Working Days of termination We may sell any property or goods over which We have a lien (and You agree that We may give good title for such property and/or goods) and shall apply the proceeds of sale firstly in discharging any costs or expenses of sale, secondly in repaying any interest or expenses owed by You to Us, thirdly in payment of any principal sums owed to Us and fourthly We shall account to You for the remainder (if any). 11. Limitations On Liability 11.1 We shall have no Liability: 11.1.1 for any loss arising from the use of the Product by an end user unless such Liability can be demonstrated to have arisen as a direct result of our wilful misconduct or recklessness in handling the supply of the Product; 11.1.2 for any defect in the Products caused or contributed to as a result of the Products being used for display or demonstration purposes or being handled by You or Your customers; 11.1.3 for defective Products and/or Services where (i) the defect has been caused or contributed to by You to the extent so contributed; (ii) You continue to use the Products or Services after giving notice of defect under clause 5; (iii) the defect arises because You failed to follow Our oral or written instructions as to the storage, installation, commissioning, use or maintenance of the Products; (iv) the defect arises as a result of Our following instructions from You to alter or amend the Products; (v) You alter or repair the Products without Our consent; or (vi) the defect arises as a result of wilful damage or negligence by You; 11.1.4 to You for breach of warranty where the Products differ from their description as a result of changes made to ensure they comply with applicable statutory or regulatory standards; 11.1.5 to You if the price for the Products and/or the Services has not been paid in full by the due date for payment; 11.1.6 to You for defective or damaged Products and/or Services and incorrect quantity of Products delivered unless the event is notified to Us within the appropriate time limit set out in the Contract; 11.1.7 to You for Products not despatched or Products lost in transit unless the event is notified to Us within 3 Working Days of such event occurring; 11.1.8 for damage, loss, liability, claims, costs, or expenses caused or contributed to by the continued use of defective Products and/or Services after a defect has become apparent or suspected or should reasonably have become apparent to You; 11.1.9 to You to the extent that You are covered by any insurance policy and You shall ensure that Your insurers waive any and all rights of subrogation they have against Us; 11.1.10 for any consequential losses, including but not limited to: loss of profits and/or damage to goodwill; economic and/or other similar losses; special damages and indirect losses; and/or business interruption, loss of business, contracts, opportunity, and/or production. 11.2 You shall: 11.2.1 give Us an opportunity to remedy any matter for which We are liable before You incur any costs and/or expenses in remedying the matter Yourself; 11.2.2 produce to Us written evidence of any claims you allege that We are liable together with written details of how the loss was caused and the steps taken by You to mitigate the loss; 11 .2.3 be under a duty to mitigate any loss, damage, costs, or expenses that You may suffer (including by maintaining an adequate stock of Products). 11.3 Our total Liability to You shall not exceed: 11.3.1 in respect of any claims relating to Clinical Trials Products, an amount equal to 10 (ten) percent of the value of the Clinical Trials Products to which the relevant claim relates; or 11.3.2 in respect of any other claims, SAR 1,000,000 (1 million Saudi Riyals). 11.4 Each of the limitations and/or exclusions on liability in the Contract shall be deemed to be applicable for each of: 11.4.1 Liability for breach of contract; 11.4.2 Liability in tort (including negligence); 11.4.3 Liability for breach of statutory duty; 11.4.4 Liability for breach of Saudi Trade Law, except clause 11.3 above which shall apply once only in respect of all the said types of Liability; and 11.4.5 All warranties, terms, conditions, and duties implied by law relating to fitness, quality, or adequacy are excluded to the fullest extent permitted by law. 11.5 Nothing in the Contract shall exclude or limit Our Liability for death or personal injury due to Our negligence or any Liability which is due to Our fraud or fraudulent misrepresentation or any other liability which it is not permitted to exclude or limit as a matter of law. 11.6 You will indemnify and keep indemnified Us against any and a ll losses, proceedings, lost profits, damages, awards, expenses, costs (including increased administration costs and legal costs on a full indemnity basis), claims, actions and any other losses and/or liabilities suffered by Us and arising directly or indirectly from or due to: 11.6.1 any loss arising from the use of the Product by an end user unless such Liability can be demonstrated to have arisen as a direct result of Our actions in handling the supply of the Product; 11.6.2 an y breach of contract, any tortious act and/or omission, and/or any breach of statutory duty by You; 11.6.3 any breach by You of Sanctions Laws; and/or 11.6.4 Our use of specifications, details, and/or stipulations supplied by You. 12. Data Privacy 12.1 Where We process your personal data in relation to the purchase of Products or Services under the Contract We will comply with any applicable data protection legislation currently in force, including but not limited to governed by the Personal data protection law (Royal Decree No. (M/19) dated 1443/2/9 AH) , the Main Principles of Personal Information Protection, and the Main Principles and General Rules for Sharing Data issued by the Saudi Data and Artificial Intelligence Authority (SDAIA) and National Data Management Office (NDMO) . any national implementing laws, regulations, and secondary legislation, as amended or updated from time to time any successor legislation thereto. 13. Anti-Bribery and Corruption 13.1 Both We and You shall not, and shall procure that Our and Your respective directors, employees, agents, representatives, contractors, or sub-contractors shall not, engage in any activity, practice, or conduct which would constitute an offense under any anti-bribery and anti-corruption laws, regulations and codes in any jurisdiction, including but not limited to the Anti-Money Laundry of Saudi Arabia 20217 and the UK Bribery Act 2010 and, where applicable, the US Foreign Corrupt Practices Act 1977 . 14. Modern Slavery 14.1 Both parties shall and shall procure that its directors and employees shall at all relevant times (a) comply (a) comply with the provisions of Anti-Trafficking in Persons Law Royal Decree no. M/40, dated 21/7/1430H ; (b) not engage in any activity, practice, or conduct that would constitute an offense under the Anti-Trafficking and Modern Slavery Statement of AcedrA if such activity, practice, or conduct were carried out in the Kingdom of Saudi Arabia; and (c) take all reasonable steps to ensure that slavery and human trafficking are not taking place in its business or its Supply Chain. 15. Sanc tions 15.1 Both We and You acknowledge the existence of Sanctions Laws. We shall ensure that We comply with all applicable Sanctions Laws to which We are subject, including those of any jurisdiction where We are located or incorporated. You shall ensure that You comply with all applicable Sanctions Laws to which You are subject, including those of any jurisdiction where You are located or incorporated. 15.2 Both We and You shall not take any action or refrain from taking any action which would, or would in the reasonable opinion of the party subject to Sanctions Laws, cause the such party to breach such Sanctions Laws. 15.3 You shall carry out appropriate due diligence with regard to any third party to whom the Products or Services are re-sold, re-supplied, re-exported, or re-transferred. You shall ensure that You have no knowledge or reasonable cause to suspect that any activities related to the Products or Services will, either directly or indirectly, involve any Sanctioned Person or will otherwise be in breach of Sanctions Laws. 15.4 In the event of Us or You becoming a Sanctioned Person, the other party may terminate any Contracts with immediate effect and without payment of compensation. 16. General 16.1 No waiver by Us of any breach of the Contract shall be considered as a waiver of any subsequent breach of the same provision or any other provision. If any provision of the Contract is held by any competent authority to be invalid or unenforceable in whole or in part the validity of the other provisions of the Contract and the remainder of the affected provision shall be unaffected and shall remain in full force and effect. 16.2 Either party shall have no Liability to the other for any delay in performance of the Contract (other than in relation to payment) where such delay is due to events outside the affected party's reasonable control including without limitation to acts of Allah, war, flood, fire, labor disputes, subcontractor delays, strikes, lock-outs, riots, civil commotion, malicious damage, explosion, governmental actions, and any other similar events. If a party is affected by such events then the time for performance shall be extended for a period equal to the period that such events delayed performance. 16.3 You shall not assign Your interest in the Contract (or any part) without Our written consent. We may assign, transfer, or sub-contract all or any part of our obligations and/or interest in the Contract to any third party without notice. 16.4 All third-party rights are excluded and no third party shall have any right to enforce the Contract. Any right of a third party to enforce the Contract may be varied and/or extinguished by agreement between the parties to the Contract without the consent of the such third party. 16.5 The Contract is governed by and interpreted in accordance with the Kingdom of Saudi Arabia law and the parties agree to submit to the exclusive jurisdiction of the Saudi Courts. AcedrA T&Cs of Purchases Consumer Information Obligations Our main activity within AcedrA relates to the supply of packaged goods/goods that are packaged to the final user of the packaging, someone who will discard that packaging. This could be postal packaging, such as if we sell products to a distributor who removes our packaging and repackages the products, or it could be selling a packaging product to the final end user. To this end, we are required under the Consumer information obligations to give our customers information about: return, collection, and recovery systems they can use their role in reusing, recovering, and recycling packaging and packaging waste what do recovery and recycling symbols on the packaging mean how to get copies of waste strategy guidance In order to achieve this AcedrA has provided links below to the relevant government websites that provide this information. the Saudi Investment Recycling Company (SIRC) AcedrA Tax Strategy BACKGROUND AcedrA is a trusted Regional and Local Leader in the highly regulated pharmaceutical industry dedicated to enabling quicker and broader access to critical medicines around the world for patients with unmet needs. Our mission is to deliver the right medicine to the right patient at the right time. AcedrA provides innovative pre and post-launch niche services to pharmaceutical and Biotechnology companies to help them accelerate development and access to their medicines and is a ’ go-to place for healthcare professionals to gain access to these critical medicines in licensed and unlicensed markets. Supplying customers in over 8 countries and shipping over 3 million units annually our business activities incur a substantial amount and variety of taxes, including corporate income tax, business rates, stamp taxes, and in the Kingdon of Saudi Arabia, employer’s national insurance. In addition, we collect and pay employment taxes and indirect taxes such as VAT. AcedrA’s core values, outlined in “Our DNA”, encourage honesty and transparency, and we pride ourselves on our integrity and openness and empower our staff to challenge management if these principles are not adhered to. In accordance with the Saudi Finance Laws for Companies , this strategy has been published online and applies to AcedrA and all its subsidiaries and applies from the date of publication until it is superseded. OUR APPROACH TO RISK MANAGEMENT AND GOVERNANCE AcedrA identifies and manages risks and opportunities, including tax risk, that may affect the achievement of its strategic objectives and business plans, its shareholder value, and its reputation, through its risk management process. The Board has responsibility for establishing and maintaining the internal control systems which are monitored to ensure compliance with laws and regulations. The Chief Financial Officer provides updates to the Board on key risks and controls within the company. Tax risk arises due to the complexity of tax legislation and potential differences in interpretation, and in relation to AcedrA’s business operating model. AcedrA has established policies and procedures to ensure the integrity of its tax filings and other tax compliance obligations in the Kingdom of Saudi Arabia and worldwide, and our processes are subject to the same level of internal controls, review, and external audit as the rest of the business. Tax risk is viewed no differently than any other business risk encountered. For routine and established tax compliance procedures, we have a very low tolerance for risk and aim for a high standard of accuracy and compliance with reporting procedures and deadlines. AcedrA has appropriately qualified finance resources who receive the necessary guidance and training to keep up to date with new tax legislation and are supported to seek additional professional tax advice where appropriate. The finance resource maintains regular lines of communication with the commercial and functional teams across the business to ensure the tax effects of business developments are identified and understood. OUR ATTITUDE TO TAX PLANNING We have a responsibility to our shareholders to ensure our operations and financial activities are conducted in a tax-efficient manner. We aim to structure our operations and finances in a tax-efficient manner which may include tax planning. This tax planning is seeking to maximize shareholders' value by utilizing available tax reliefs, incentives, and exemptions where appropriate and ensuring that any arrangements are in the spirit of and comply with the tax legislation in question. Professional advice is sought on a transactional basis, with the depth of that advice driven by our assessment of the risk presented and the level of complexity involved. LEVEL OF TAX RISK WE ARE PREPARED TO ACCEPT AcedrA’s approach to tax planning is to ensure compliance with tax laws and regulations, both in the Kingdom of Saudi Arabia and worldwide, and to ensure that we identify and mitigate tax risks. Tax risk is assessed for each significant transaction. We have no defined limit of the risk we are prepared to accept, we will assess, manage and mitigate the tax risk to an acceptable level on a case-by-case basis. We maintain relationships with reputable external tax advisors that allow us to seek expert advice on specialist areas of tax, and in situations where the tax law is unclear or where internal expertise is insufficient. OUR APPROACH TO DEALING WITH TAX AUTHORITIES AcedrA seeks to ensure its engagement with the Saudi Zakat, Tax and Customs Authority (and other tax authorities in other jurisdictions) is professional, open and honest, and undertaken in the spirit of cooperation. Our aim is to work collaboratively and proactively with tax authorities to resolve matters arising which may include areas such as where legislation or guidance is unclear and there is a significant tax impact. We aim to respond to requests for information in a timely manner and we submit all returns on time. Where appropriate the company seeks advance clearance from tax authorities on the proposed tax treatment of transactions. ​ Reviewed and Updated on 20th of March 2023 AcedrA Board of Directors AcedrA CEO Department AcedrA Compliance Department AcedrA Finance Department AcedrA Operations Department Acedra Commercial Department ​ Hotline: (Toll-Free) 8001240411 legal.affairs@acedrarx.com

QUI NOUS SOMMES Nous sommes un groupe d'entrepreneurs et d'ingénieurs jeunes et talentueux avec une idée révolutionnaire qui, nous l'espérons, contribuera à un avenir meilleur. Nous fournissons des solutions intelligentes aux entreprises de toutes tailles et sommes fiers de notre service dévoué et inégalé. Chez AcedrA BioPharmaceuticals, nous pensons qu'une bonne compréhension et une avance technologique peuvent conduire les entreprises vers un avenir prospère. Nous recherchons toujours de précieux commentaires de nos clients afin d'apprendre et d'évoluer. Contactez-nous dès aujourd'hui pour organiser une rencontre avec l'un de nos représentants commerciaux ou demander une démonstration. Nous contacter RENCONTRER L'ÉQUIPE WATTS DE RIVIÈRE JESSE NEIMUS JAMES MORGAN OPPORTUNITÉS D'EMPLOI À la recherche des meilleurs talents COORDONNATEUR DES FINANCES ET DES OPÉRATIONS Contrat RESPONSABLE ADMINISTRATIF À plein temps CHEF DE PRODUIT À temps partiel Vacancies Get in Touch

Business Units At AcedrA, we understand the value of strategic business units and their ability to create synergy within a business. That's why our business is organized into three distinct business units: Unmet Commercial Needs, Unmet Medical Needs, and Medical Technology. By utilizing business units, we enable cross-functional collaboration between departments and foster an environment of innovation and creativity that can help meet business goals. Our business units allow us to focus on specific areas of therapeutics, develop unique solutions, and create greater value for the patients' communities and scientific societies. As we continue to grow and evolve as a business, it's important that we stay focused on strategic business units in order to maximize our potential. We believe that the business units we have created will help us to create a more innovative and successful business. We are excited to continue our journey forward with business units at AcedrA and remain confident in our ability to move the business forward. With strategic business units, we are ready to take on any challenge and confidently move forward toward success. At AcedrA, business units are the foundation of our business and embody our commitment to crafting innovative solutions for our customers. As we move forward, we look forward to continuing to leverage business units in order to create greater value for all stakeholders. Together, let's build something great! Unmet Medical Needs We have a team of dedicated, passionate professionals who are working to revolutionize the process of making groundbreaking treatments available to patients with unmet medical needs, they take pride in their innovative approach to identifying diseases with no existing treatment options or with low alternatives and bridging with novel solutions to serve those populations. Discover Unmet Commercial Needs At AcedrA, we believe that all patients should have access to the best possible care available. That's why our team is dedicated to finding new and innovative ways to make treatments more accessible and affordable. By exploring existing methods of care, we are committed to providing solutions that benefit both patients and providers alike. Discover Medical Technology At AcedrA Medical Technology Business Unit, we are revolutionizing care with cutting-edge products and services. Our team of experts is using innovative solutions to drive advances in patient care while reducing healthcare costs. We believe that with the right technology, anything is possible. ​ Discover Si vous avez des commentaires sur la gouvernance d'AcedrA, laissez-nous un message et nous vous répondrons. Prénom Nom de famille E-mail Sujet Tapez votre message ici... Nous faire parvenir Merci d'avoir soumis ! Partnership Access Sourcing